Selective magnesiation of chloro-iodopurines: An efficient approach to new purine derivatives

Organic Letters

Volumn 8, Issue 7, 2006, Pages 1291-1294

  Tobrman, Tomáš ^a   Dvořák, Dalimil ^a  

^a INSTITUTE OF CHEMICAL TECHNOLOGY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

HALOGENATED HYDROCARBON; MAGNESIUM; PURINE DERIVATIVE;

ARTICLE; CATALYSIS; CHEMICAL STRUCTURE; CHEMISTRY; SYNTHESIS;

CATALYSIS; HYDROCARBONS, HALOGENATED; MAGNESIUM; MOLECULAR STRUCTURE; PURINES;

EID: 33645951409     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol053013w     Document Type: Article

References (35)

1. (a) Havlíček, L.; Hanuš, J.; Veselý, J.; Leclerc, S.; Meijer, L.; Shaw, G.; Strnad, M. J. Med. Chem. 1997, 40, 408.
2. (b) Legraverend, M.; Ludwig. O.; Bisagni, E.; Leclerc, S.; Meijer, L. Bioorg. Med. Chem. Lett. 1998, 8, 793.
3. (c) Legraverend, M.; Ludwig, O.; Bisagni, E.; Leclerc, S.; Meijer, L.; Giocanti, N.; Sadri, R.; Favaudon, V. Bioorg. Meet. Chem. 1999, 7, 281.
4. (d) Gray, N. S.; Wodicka, L.; Thunnissen, A.-M. W. H.; Nornam, T. C.; Kwon, S.; Espinoza, F. H.; Morgan, D. O.; Barnes, G.; LeClerc, S.; Meijer, L.; Kim, S.-H.; Lockhart, D. J.; Schultz, P. G. Science 1998, 281, 533.
5. (e) Chang, Y.-T.; Gray, N. S.; Rosania, G. R.; Sutherlin, D. P.; Kwon, S.; Norman, T. C.; Sarohia, R.; Leost, M.; Meijer, L.; Schultz, P. G. Chem. Biol. 1999, 6, 361.
6. Meijer, L. Trends Cell Biol. 1996, 6, 393.
7. Verdugo, D. E.; Cancilla, M. T.; Ge, X.; Gray, N. S.; Chang, Y.-T.; Schultz, P. G.; Negishi, M.; Leary, J. A.; Bertozzi, C. R. J. Med. Chem. 2001, 44, 2683.
8. (a) Rosania, G. R.; Chang, Y.-T.; Perez, O.; Sutherlin, D.; Dong, H. L.; Lockhart, D. J.; Schultz, P. G. Nat. Biotechnol. 2000, 18, 304.
9. (b) Chang, Y.-T.; Wignall, S. M.; Rosania, G. R.; Gray, N. S.; Hanson, S. R.; Su, A. I.; Merlie, J.; Moon, H. S.; Sangankar, S. B.; Perez., O.; Heald, R.; Schultz, P. G. J. Med. Chem. 2001, 44, 4497.
10. (c) Franěk, F.; Siglerová, V.; Havlíček, L.; Strnad, M.; Eckschlager, T.; Weigl, E. Collect. Czech. Chem. Commun. 2002, 67, 257.
11. Cocuzza, A. J.; Chidester, D. R.; Culp, S.; Fitzgerald, L.; Gilligan, P. Bioorg. Med. Chem. Lett. 1999, 9, 1063.
12. Erion, M. D.; Reddy, M. R. J. Am. Chem. Soc. 1998, 120, 3295.
13. (a) Evans, B.; Wolfenden, R. J. Am. Chem. Soc. 1970, 92, 4751.
14. (b) Wolfenden, R.; Wentworth, D. F.; Mitchell, G. N. Biochemistry 1977, 16, 5071.
15. Šilhár, P.; Pohl, R.; Votruba, I.; Hocek, M. Org. Lett. 2004, 6, 3225.
16. (a) Leonard, N. J.; Bryant, J. D. J. Org. Chem. 1979, 44, 4612.
17. (b) Cong-Dahn, N.; Beacourt, J.-P.; Pichat, L. Tetrahedron Lett. 1979, 20, 2385.
18. (c) Barton, D. H. R.; Hedgecock, C. J. R.; Lederer, E.; Motherwell, W. B. Tetrahedron Lett. 1979, 20, 279.
19. (d) Tanaka, H.; Uchida, Y.; Shinozaki, M.; Hayakawa, H.; Matsuda, A.; Miyasaka, T. Chem. Pharm. Bull. 1983, 31, 787.
20. (e) Hayakawa, H.; Haraguchi, K.; Tanaka, H.; Miyasaka, T. Chem. Pharm. Bull. 1987, 35, 72.
21. (f) Hayakawa, H.; Tanaka, H.; Sasaki, K.; Haraguchi, K.; Saitoh, T.; Takai, F.; Miyasaka, T. J. Heterocycl. Chem. 1989, 26, 189.
22. (g) Czechtizky, W.; Vasella, A. Helv. Chim. Acta 2001, 84, 594.
23. Tobrman, T.; Dvořák, D. Org. Lett. 2003, 5, 4289.
24. Legraverend, M.; Ludwig. O.; Bisagni, E.; Leclerc, S.; Meijer, L.; Giocanti, N.; Sadri, R.; Favaudon. V. Bioorg. Med. Chem. 1999, 7, 1281.
25. This compound was prepared by benzylation of 2-chloro-6-iodopurine, which was prepared from 2,6-dichloropurine by an exchange reaction with concentrated hydroiodic acid: Elion, G. B.; Hitchings, G. H. J. Am. Chem. Soc. 1956, 78, 3508. The position of halogens in the above paper was only estimated. Thus, the reaction described in Scheme 2 is also proof that the compound obtained from 2.6-dichloropurine by reaction with hydroiodic acid is 2-chloro-6-iodopurine and not isomeric 6-chloro-2-iodopurine.
26. The outcome of the reaction with 1 equiv of RMgCl strongly depends on the reaction temperature. Thus, the reaction with iPrMgCl at -80 °C followed with addition of water at -80 °C affords exclusively 5, whereas the same reaction at higher temperatures gives mixtures of 5 and 7a in a different ratio. Interestingly, formation of 9-benzyl-6-iodopurine or 6-isopropyl-2-chloropurine was not observed. It suggests that a Cl/Mg exchange reaction is connected with the introduction of an alkyl group to the 6 position. However, all attempts to prepare 6-alkyl-2-chloro-9-benzylpurines as putative intermediates of the formation of 9 failed.
27. Nguyen, C.-D.; Beaucourt, J.; Pichat, L. Tetrahedron Lett. 1979, 20, 3159.
28. (a) Bergstrom, D. E.; Reddy, P. A. Tetrahedron Lett. 1982, 23, 4191.
29. (b) Estep, K. G.; Josef, K. A.; Bacon, E. R.; Carabates, P. M.; Rumney, S.; Pilling, G. M.; Krafte, D. S.; Volberg, W. A.; Dillon, K.; Dugrenier, N.; Briggs, G. M.; Canniff, P. C.; Gorczyca, W. P.; Stankus, G. P.; Ezrin, A. M. J. Med. Chem. 1995, 38, 2582.
30. (c) Sugimura, H.; Takei, H. Bull. Chem. Soc. Jpn. 1985, 58, 664.
31. (a) Fürstner, A.; Leitner, A.; Méndez, M.; Krause, H. J. Am. Chem. Soc. 2002, 124, 13856.
32. (b) Hocek, M.; Dvořáková, H. J. Org. Chem. 2003, 68, 5773.
33. (c) Hocek, M.; Hocková, D.; Dvořáková, H. Synthesis 2004, 889.
34. (d) Hocek, M.; Pohl, R. Synthesis 2004, 2869.
35. Preliminary results show that 2-magnesiated purines are stabilized by electron-donating substituents in the 6 position of purine nuclei.